We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+20.62%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$344B
AUM Growth
+$47.8B
Cap. Flow
-$1.28B
Cap. Flow %
-0.37%
Top 10 Hldgs %
12.06%
Holding
3,896
New
276
Increased
1,854
Reduced
1,496
Closed
132

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$707M
2
DIS icon
Walt Disney
DIS
+$452M
3
AVB icon
AvalonBay Communities
AVB
+$351M
4
LLY icon
Eli Lilly
LLY
+$285M
5
AAPL icon
Apple
AAPL
+$283M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Consumer Discretionary 13.11%
3 Healthcare 12.92%
4 Financials 12.43%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REFR icon
3626
Research Frontiers
REFR
$13.6M
$62K ﹤0.01%
+22,118
New +$62.4K
ITI
3627
DELISTED
Iteris, Inc.
ITI
$62K ﹤0.01%
+11,081
New +$52.9K
MBII
3628
DELISTED
Marrone Bio Innovations, Inc.
MBII
$62K ﹤0.01%
+49,486
New +$59K
CALA
3629
DELISTED
Calithera Biosciences, Inc
CALA
$62K ﹤0.01%
+622
New +$54.5K
TXMD icon
3630
TherapeuticsMD
TXMD
$23.8M
$61K ﹤0.01%
1,008
+717
+246% +$49K
XAIR icon
3631
Beyond Air
XAIR
$3.97M
$61K ﹤0.01%
+29
New +$63.5K
MIE
3632
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$61K ﹤0.01%
26,294
-11,067
-30% -$22.3K
AGFS
3633
DELISTED
AgroFresh Solutions Inc
AGFS
$60K ﹤0.01%
+26,412
New +$62.3K
CEMI
3634
DELISTED
Chembio diagnostics, Inc.
CEMI
$60K ﹤0.01%
+12,601
New +$65.1K
STXS icon
3635
Stereotaxis
STXS
$133M
$58K ﹤0.01%
+11,323
New +$46.3K
BBAR icon
3636
BBVA Argentina
BBAR
$3.85B
$57K ﹤0.01%
17,858
-727
-4% -$2.15K
MTVA
3637
MetaVia Inc
MTVA
$7.44M
$57K ﹤0.01%
+4
New +$60.1K
ATHX
3638
DELISTED
Athersys, Inc. Common Stock
ATHX
$57K ﹤0.01%
+1,293
New +$58.8K
AMPY icon
3639
Amplify Energy
AMPY
$158M
$56K ﹤0.01%
42,800
-1,849
-4% -$1.83K
LITS
3640
Lite Strategy Inc
LITS
$32.4M
$56K ﹤0.01%
+1,052
New +$60.7K
LNAI
3641
Lunai Bioworks
LNAI
$9.57M
$56K ﹤0.01%
+239
New +$60.4K
SCPH
3642
DELISTED
scPharmaceuticals
SCPH
$56K ﹤0.01%
+10,533
New +$82.5K
NMRD
3643
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$56K ﹤0.01%
+14,961
New +$57.7K
SBBP
3644
DELISTED
Strongbridge Biopharma plc.
SBBP
$56K ﹤0.01%
+23,059
New +$55.6K
CDTX
3645
DELISTED
Cidara Therapeutics
CDTX
$55K ﹤0.01%
+1,378
New +$68.5K
VTVT icon
3646
vTv Therapeutics
VTVT
$124M
$55K ﹤0.01%
+742
New +$56.9K
IBIO icon
3647
iBio
IBIO
$67.6M
$53K ﹤0.01%
+101
New +$82.3K
AXLA
3648
DELISTED
Axcella Health Inc. Common Stock
AXLA
$53K ﹤0.01%
+412
New +$52.9K
AGRX
3649
DELISTED
Agile Therapeutics
AGRX
$53K ﹤0.01%
+9
New +$53K
GALT icon
3650
Galectin Therapeutics
GALT
$230M
$52K ﹤0.01%
+23,434
New +$61.5K

Similar funds

Invesco's Q4 2020 Portfolio in Review

As of Q4 2020, Invesco held 3,896 positions worth $344B, up 16% from $296B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Invesco's Q4 2020 filing shows 276 new, 1,854 increased, 1,496 reduced and 132 closed positions. Its largest new stake was Array Technologies: 3,528,447 shares worth $152M. The largest sale was Alibaba, an estimated $932M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Invesco's largest Q4 2020 buy was Array Technologies: 3,528,447 shares worth $152M.
  • Invesco added most to Pinduoduo in Q4 2020, an estimated $707M increase.
  • Invesco's biggest Q4 2020 reduction was Alibaba, cutting an estimated $932M.
  • Invesco fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $176M.
  • Invesco's ten largest holdings make up 12% of its $344B portfolio in Q4 2020.
  • Invesco opened 276 new positions and closed 132 in Q4 2020.
  • Invesco's portfolio value rose 16% quarter-over-quarter to $344B.

Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.